Kramer, M. Kaye

Adherence to Preventive Medications

Walker, E. A., Molitch, M., Kramer, M. K., Kahn, S., Ma, Y., Edelstein, S., Smith, K., Johnson, M. K., Kitabchi, A., Crandall, J., et al. (2006) · Diabetes Care

Medication Adherence and ComplianceDiabetes Management and Education

Cited by 161

Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Diabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 128

A novel approach to diabetes prevention: Evaluation of the Group Lifestyle Balance program delivered via DVD

Kramer, M. K., Kriska, A. M., Venditti, E. M., Semler, L. N., Miller, R. G., McDonald, T., Siminerio, L. M., & Orchard, T. J. (2010) · Diabetes Research and Clinical Practice

Diabetes Management and EducationDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 90

The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures

Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

Evaluation of a diabetes prevention program lifestyle intervention in older adults: A randomized controlled study in three senior/community centers of varying socioeconomic status

Kramer, M. K., Vanderwood, K. K., Arena, V. C., Miller, R. G., Meehan, R., Eaglehouse, Y. L., Schafer, G., Venditti, E. M., & Kriska, A. M. (2018) · The Diabetes Educator

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Education

Cited by 46

Research aimed at improving both mood and weight (RAINBOW) in primary care: A type 1 hybrid design randomized controlled trial

Ma, J., Yank, V., Lv, N., Goldhaber-Fiebert, J. D., Lewis, M. A., Kramer, M. K., Snowden, M. B., Rosas, L. G., Xiao, L., & Blonstein, A. C. (2015) · Contemporary Clinical Trials

Obesity and Health PracticesDiabetes Management and Education

Cited by 45

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29

Evaluation of physical activity reporting in community Diabetes Prevention Program lifestyle intervention efforts: a systematic review

Eaglehouse, Y. L., Kramer, M. K., Rockette-Wagner, B., Arena, V. C., & Kriska, A. M. (2015) · Preventive Medicine

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 16